Stocks To Buy Now

Blog


Summit Recap: 8th Digital Strategy & Innovation for Medical Affairs

The 8th Digital Strategy & Innovation for Medical Affairs Summit took place on June 5-6, 2024, in Philadelphia. This event brought together professionals from pharmaceutical, biotechnology, and medical device sectors to explore the latest digital engagement strategies and innovations in medical affairs. Key topics included leveraging AI to improve patient outreach, tracking the patient journey with digital technologies, and developing effective digital engagement strategies.

The summit featured expert presentations, panel discussions, and interactive workshops, allowing attendees to gain insights into best practices and emerging trends. Participants had the opportunity to network with industry leaders and peers, fostering collaborations and sharing experiences on how to navigate the rapidly evolving digital landscape in medical affairs. The speaking faculty joined from various organizations, including AstraZeneca, Bayer, Pfizer, and Takeda.

For those unable to attend the event in person, an On-Demand option is available, enabling participants to watch the summit sessions at their convenience from anywhere. This ensures that the valuable knowledge and insights shared during the summit are accessible to a broader audience.

Learn more: https://dgevents.com/event/8th-digital_strategy-innovation-for-medical-affairs-summit/

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

February 2, 2026

Cutaneous T-cell lymphoma (“CTCL”) remains a cancer with limited treatment options, persistent symptoms and long-term quality-of-life challenges for patients, even decades after its classification as a distinct disease. Despite medical advances in oncology, many people living with CTCL continue to cycle through therapies that offer only partial relief or introduce new burdens. Soligenix (NASDAQ: SNGX) […]

Rotate your device 90° to view site.